Levepsy 1000 Tablet contains Levetiracetam 1000mg, an antiepileptic agent indicated for the treatment of partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam’s exact mechanism of action is not fully understood; however, it is believed to modulate synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby inhibiting abnormal neuronal excitability. Levepsy 1000 Tablet is typically prescribed as adjunctive therapy in adults and pediatric patients aged four years and above. The medication is rapidly absorbed following oral administration, with peak plasma concentrations achieved within one hour, and it is predominantly excreted unchanged via the kidneys. Dose adjustments may be necessary in patients with renal impairment to avoid toxicity. Common adverse effects include somnolence, dizziness, fatigue, and behavioral changes such as irritability or agitation. It is essential to monitor patients for mood alterations and suicidal ideation during therapy. Levepsy 1000 Tablet should be used under strict medical supervision, with gradual dose titration recommended to minimize side effects. Patients should not discontinue therapy abruptly due to the risk of increased seizure frequency. This medication is contraindicated in individuals with known hypersensitivity to Levetiracetam or any of its excipients.